O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.11%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$9.48B
AUM Growth
+$9.48B
(+0.07%)
Cap. Flow
-$371M
Cap. Flow
% of AUM
-3.91%
Top 10 Holdings %
Top 10 Hldgs %
38.1%
Holding
152
New
12
Increased
38
Reduced
32
Closed
19
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$130M |
| 2 |
Merck
MRK
|
$98.2M |
| 3 |
Molina Healthcare
MOH
|
$91.7M |
| 4 |
Zimmer Biomet
ZBH
|
$91.4M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
$90.5M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$189M |
| 2 |
CELG
Celgene Corp
CELG
|
$135M |
| 3 |
HCA Healthcare
HCA
|
$126M |
| 4 |
AGN.PRA
Allergan plc.
AGN.PRA
|
$95.8M |
| 5 |
TSRO
TESARO, Inc.
TSRO
|
$84.2M |
Sector Composition
| 1 | Healthcare | 90% |
| 2 | Financials | 0.34% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDVN
26
DELISTED
MEDIVATION, INC.
MDVN
| $121M | 1.26% |
2,001,400
+1,500,400
| +299% | +$90.5M |
|
27
Illumina
ILMN
$15.2B
| $119M | 1.24% |
846,200
-53,800
| -6% | -$7.55M |
|
28
BioMarin Pharmaceuticals
BMRN
$11.3B
| $118M | 1.23% |
1,518,500
+495,300
| +48% | +$38.5M |
|
29
Eli Lilly
LLY
$661B
| $116M | 1.21% |
1,476,800
-1,064,500
| -42% | -$83.8M |
|
30
Cooper Companies
COO
$13.3B
| $116M | 1.21% |
676,300
-119,600
| -15% | -$20.5M |
|
|
WMGI
31
DELISTED
Wright Medical Group Inc
WMGI
| $114M | 1.19% |
6,545,163
-1,799,947
| -22% | -$31.3M |
|
|
32
Merck
MRK
$210B
| $110M | 1.15% |
1,915,500
+1,705,100
| +810% | +$98.2M |
|
|
ISEE
33
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $110M | 1.14% |
2,148,100
+53,600
| +3% | +$2.74M |
|
|
34
Zimmer Biomet
ZBH
$20.8B
| $104M | 1.08% |
862,500
+759,500
| +737% | +$91.4M |
|
35
Johnson & Johnson
JNJ
$429B
| $94.3M | 0.98% |
777,600
+245,800
| +46% | +$29.8M |
|
|
36
Molina Healthcare
MOH
$9.6B
| $91.7M | 0.96% |
+1,838,000
| New | +$91.7M |
|
|
ACHN
37
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $91.1M | 0.95% |
11,681,600
+161,900
| +1% | +$1.26M |
|
38
Puma Biotechnology
PBYI
$258M
| $88.3M | 0.92% |
2,964,025
+210,600
| +8% | +$6.27M |
|
|
AGN.PRA
39
DELISTED
Allergan plc.
AGN.PRA
| – | – |
-104,200
| Closed | -$95.8M |
|
40
Glaukos
GKOS
$5.42B
| $84.5M | 0.88% |
2,897,938
| – | – |
|
41
Neurocrine Biosciences
NBIX
$13.5B
| $82.5M | 0.86% |
1,815,474
-838,400
| -32% | -$38.1M |
|
|
MNK
42
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $79.6M | 0.83% |
1,309,000
| – | – |
|
43
Corvus Pharmaceuticals
CRVS
$419M
| $76.7M | 0.8% |
5,379,349
+120,899
| +2% | +$1.72M |
|
|
SHPG
44
DELISTED
Shire pic
SHPG
| $72.5M | 0.76% |
394,009
+93,638
| +31% | +$17.2M |
|
|
MGLN
45
DELISTED
Magellan Health Services, Inc.
MGLN
| $71.7M | 0.75% |
1,090,600
-818,400
| -43% | -$53.8M |
|
46
Humana
HUM
$37.5B
| $61.1M | 0.64% |
339,700
| – | – |
|
|
INSY
47
DELISTED
Insys Therapeutics, Inc.
INSY
| $60.7M | 0.63% |
4,688,240
+130,500
| +3% | +$1.69M |
|
48
Medtronic
MDT
$118B
| $57.8M | 0.6% |
666,299
| – | – |
|
49
Intellia Therapeutics
NTLA
$1.26B
| $56.8M | 0.59% |
+2,662,180
| New | +$56.8M |
|
|
BLUE
50
DELISTED
bluebird bio
BLUE
| $51.3M | 0.54% |
1,185,800
+240,300
| +25% | +$10.4M |
|